News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Lung Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Lung Therapeutics, Inc. reports a 2.1% stake in TFF Pharmaceuticals, Inc. |
| 04/04/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 02/14/2022 |
SC 13G/A
| Lung Therapeutics, Inc. reports a 8.8% stake in TFF Pharmaceuticals, Inc. |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/08/2020 |
4
| Lung Therapeutics, Inc. (10% Owner) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 500,000 shares
@ $13.85, valued at
$6.9M
Sold 300,000 shares
@ $13.86, valued at
$4.2M
Sold 250,000 shares
@ $13.86, valued at
$3.5M
|
|
| 02/03/2020 |
SC 13G
| Lung Therapeutics, Inc. reports a 21.7% stake in TFF Pharmaceuticals, Inc. |
| 10/31/2019 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 06/18/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/19/2017 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
| 02/24/2017 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
| 03/08/2016 |
D
| Form D - Notice of Exempt Offering of Securities |
|
|